Brief: BioArctic's Leqembi Approved In South Korea
24/05/2024 11:57
May 24 (Reuters) - BioArctic AB BIOAb.ST :
* LEQEMBI ® APPROVED FOR THE TREATMENT OF ALZHEIMER'S
DISEASE IN
SOUTH KOREA
Source text for Eikon: ID:nWkr501pyj
Further company coverage: BIOAb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on BioArctic AB
See all newsBrief: BioArctic And Lilly Sign Research, Collaboration Agreement
Brief: Bioarctic AB Declares Dividend Of Sek 2 Per Share With 1 June 2026 Record Date
Brief: Bioarctic Partner Eisai Presents Leqembi Sales Simulation
Sweden's BioArctic Q1 revenue drops sharply despite higher Leqembi royalties
Brief: BioArctic Q1 Operating Profit SEK 210.8 Million